| [1] |
FENG Hao, GUO Xiaoshuang, REN Xiaojing, LI Ming.
Analysis of the therapeutic effect of Wuzhuyu decoction combined with dolasetron mesylate in the treatment of chemotherapy-induced vomiting
[J]. Tianjin Medical Journal, 2026, 54(2): 201-205.
|
| [2] |
HUANG Wei, WANG Jianjian, HUANG Ying, YANG Jun.
The effect of compound Kushen Injection combined with chemotherapy and bevacizumab on short-term efficacy of patients with ovarian cancer
[J]. Tianjin Medical Journal, 2026, 54(1): 88-92.
|
| [3] |
Tianjin Anti-Cancer Association Committee of Rehabilitation and Palliative Care, Tianjin Medical Doctor Association Committee of Tumor Multidisciplinary Diagnosis and Treatment .
Tianjin expert consensus on the prevention and treatment of refractory chemotherapy-related nausea and vomiting (2025 edition)
[J]. Tianjin Medical Journal, 2025, 53(1): 1-8.
|
| [4] |
QIN Hanlin, HU Changlu, ZHAO Yamei, NIU Weina.
Effect and safety of quadruple regimen in preventing multi-day cisplatin-based chemotherapy induced nausea and vomiting
[J]. Tianjin Medical Journal, 2024, 52(8): 835-839.
|
| [5] |
WU Qian, WANG Yi, CHEN Nian, ZHOU Kai, TIAN Xin, XU Hui, GOU Xiaoxia.
Effect of induction chemotherapy on immune function and inflammatory indicators in patients with nasopharyngeal carcinoma
[J]. Tianjin Medical Journal, 2024, 52(4): 397-402.
|
| [6] |
LIU Yan, XU Jing, MA Lei, CAO Guanya, ZHAO Fengde.
The relationship between EOS, D-D and NLR in peripheral blood and pulmonary ventilation in patients with AECOPD
[J]. Tianjin Medical Journal, 2024, 52(12): 1261-1265.
|
| [7] |
ZHAO Jiajia, WAN Wenjun, YANG Heyu, XIE Min, LIU Ling.
ANA-12 relieves oxaliplatin-induced chemotherapy pain in rats by targetly inhibiting BDNF/TrkB signal
[J]. Tianjin Medical Journal, 2023, 51(1): 35-40.
|
| [8] |
ZHANG Manli, LIU Weiwei, WANG Lijuan, LI Weidong.
The correlation between the level of reticulin 1C in peripheral blood mononuclear cells and the efficacy of neoadjuvant chemotherapy for triple negative breast cancer
[J]. Tianjin Medical Journal, 2023, 51(1): 69-73.
|
| [9] |
HU Jiahai, XUE Song, CHEN Quan.
Effects of camrelizumab combined with chemotherapy on serum miR-21 and soluble E-cadherin in patients with advanced esophageal cancer
[J]. Tianjin Medical Journal, 2022, 50(8): 873-877.
|
| [10] |
YI Wanping, MA Deshou.
High-intensity focused ultrasound enhances cisplatin chemotherapy sensitivity of breast cancer through TRIF-mediated ERK pathway
[J]. Tianjin Medical Journal, 2022, 50(7): 698-706.
|
| [11] |
ZHU Lina, WANG Jupeng, SONG Yalin, FENG Jihong, MA Mingkun, WEN Xuehong△.
Application of antineutrophil cytoplasmic antibodies and related laboratory parameters in patients with pulmonary fibrosis
[J]. Tianjin Medical Journal, 2022, 50(1): 94-98.
|
| [12] |
LI Yun-hua, YAN Xue-jun, TAN Ya-li, HU Ya, XIAO Mao-liang.
Long-term prognostic analysis of simultaneous integration and intensity modulation
combined with selective lymph node radiation radical therapy for
esophageal squamous cell carcinoma
[J]. Tianjin Medical Journal, 2021, 49(12): 1297-1302.
|
| [13] |
LI Xiao-shuang, MA Fei, SUN Xiao-ying, LIU Chang, HAO Jing-hong.
The effect of dyslipidemia on liver function after the first chemotherapy in breast cancer patients
[J]. Tianjin Medical Journal, 2021, 49(10): 1081-1085.
|
| [14] |
XIA Yu-mei, TANG Jing, LI Hui, XU Ci, QIN Qi-xiong, QUAN Xue-mei, CHEN Ya, LIANG Zhi-jian△.
Clinical features and possible pathogenesis of pancreatic cancer-related cerebral infarction
[J]. Tianjin Medical Journal, 2020, 48(8): 744-748.
|
| [15] |
SONG Chun-yang, ZHU Shu-chai, SHEN Wen-bin, GAO Si-na, SU Jing-wei, LI Juan, ZHAO Yan, XU Jin-rui, LI Shu-guang, LIU Zhi-kun.
Influence factors for prognosis of stage Ⅱ-Ⅲ esophageal carcinoma patients treated with radical esophagectomy
[J]. Tianjin Medical Journal, 2020, 48(3): 209-215.
|
